Witte J, Lloyd M, Lorenzsonn V, Korsmo H, Olsen W
Gastroenterology Research Laboratory, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705.
J Clin Invest. 1990 Oct;86(4):1338-42. doi: 10.1172/JCI114843.
The intestinal brush-border enzyme lactase splits lactose into its component monosaccharides, glucose and galactose. Relative deficiency of the enzyme during adulthood is a common condition worldwide and is frequently associated with symptoms of lactose intolerance. We studied the synthesis and processing of lactase in normal and adult hypolactasic subjects using human intestinal explants in organ culture. Metabolic labeling experiments in our control subjects with [35S]methionine followed by immunoprecipitation, sodium dodecyl sulfate-polyacrylamide-gel electrophoresis, and fluorography demonstrated that newly synthesized lactase is initially recognized as a precursor molecule with a relative molecular weight (Mr) of 205,000. Over the course of several hours most of the labeled lactase was converted to a mature form of 150,000 Mr. Transiently appearing forms of 215,000 and 190,000 Mr were identified and were felt to represent intermediary species generated during intracellular processing. We identified two distinct alterations in lactase biosynthesis accounting for adult hypolactasia. Studies in three deficient subjects demonstrated markedly reduced synthesis of the precursor protein though posttranslational processing appeared identical to normal. Multiple studies in a fourth deficient subject demonstrated synthesis of ample amounts of precursor lactase but reduced conversion to the mature active form of the enzyme.
肠刷状缘酶乳糖酶可将乳糖分解为其组成单糖,即葡萄糖和半乳糖。在成年人中,该酶相对缺乏是一种全球普遍存在的情况,且常与乳糖不耐受症状相关。我们利用器官培养中的人肠道外植体,研究了正常和成年低乳糖酶受试者中乳糖酶的合成与加工过程。在我们的对照受试者中,用[35S]甲硫氨酸进行代谢标记实验,随后进行免疫沉淀、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和荧光自显影,结果表明新合成的乳糖酶最初被识别为相对分子质量(Mr)为205,000的前体分子。在数小时的过程中,大部分标记的乳糖酶转化为Mr为150,000的成熟形式。鉴定出了Mr为215,000和190,000的短暂出现形式,认为它们代表细胞内加工过程中产生的中间物种。我们确定了乳糖酶生物合成中的两种不同改变,这可解释成年低乳糖酶症。对三名缺陷受试者的研究表明,前体蛋白的合成明显减少,尽管翻译后加工似乎与正常情况相同。对第四名缺陷受试者的多项研究表明,合成了大量的前体乳糖酶,但转化为该酶成熟活性形式的过程减少。